Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortio

来源 :中国免疫学会第十届全国免疫学学术大会 | 被引量 : 0次 | 上传用户:heatsink
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: To comparatively analyze the circulating microRNA (miRNA) profiling between unexplained recurrent spontaneous abortion (URSA) and normal early pregnancies (NEP) by microarray, and to evaluate the potential role of circulating miRNA as a biomarker for URSA.
其他文献
Background and Objectives: Type 1 regulatory T cell (Tr1) is an inducible subset of regulatory T cells, characterized by the capability to secrete immunosuppressive cytokine IL-10.
Objective: The purpose of this study was to investigate the clinical and serological characteristics of Primary Sjgrens syndrome (pSS) patients with different proportion of IgG4-positve plasma cells i
Aloperine has been recognized with the potential capacity to treat inflammatory and allergic diseases as well as colitis.Treg plays a key role in IBD.
Objective: Bone marrow-derived mesenchymal stem cells (MSCs) could exert a potent immunosuppressive effect, and therefore may have a therapeutic potential in T-cell-dependent pathologies.
Objective: Here we examined whether the expression of a novel immunoregulatory gene set could be used to predict outcomes in murine models of rapamycin-induced cardiac tolerance, spontaneous hepatic t
Objective: The development of an animal model bearing definite antigens is important to facilitate the evaluation and modulation of specific allo-antigen responses after transplantation.
Objective: Organ transplant recipients have elevated cancer and viral infection risks due to immunosuppression and long-term results of organ transplantation remain unsatisfactory, mainly because of c
Objective: Ischemic preconditioning (IPC) exerts a protective effect in hepatic ischemia/reperfusion (I/R) injury.The exact mechanism of IPC action remains largely unknown.
背景:肝移植后长期的免疫抑制剂如他克莫司(FK506)的应用会带来许多严重的副作用如感染、肾毒性、代谢紊乱等。肝移植他克莫司最小化应用是最终目标。材料与方法:本研究分为三部分分别对肝移植后短期(4周)、长期(10年以上)受者FK506浓度进行优化,第三部分对FK506剂型进行优化:第一部分:对本中心2009年到2011年235例移植病人进行回顾性分析,根据术后1月内FK506平均浓度及变异程度(S
Aim: To explore the role of IL-22 in GVHD and the properties of IL-22-producing cells.Materials and Methods: GVHD mice model were established and treated with murine IL-22 or PBS respectively.